Evid Invest
Who owns LTGOWhat LTGO owns — n/a

Who owns Latigo Biotherapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of LTGO from SEC Form 13F filings across 58 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 58 institutions disclosed 41.8M shares of Latigo Biotherapeutics, Inc. worth $697.3M — about 110.3% of shares outstanding; the largest disclosed holder is 5AM Venture Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

58

13F holders

$697.3M

value, 2026 filers

110.3%

of shares outstanding (41.8M sh)

58

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of LTGO's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
15AM Venture Management, LLCNEW7.3M$122.3M41.2%19.4%new
2RA CAPITAL MANAGEMENT, L.P.NEW5.3M$88.6M0.9%14%new
3Deep Track Capital, LPNEW4.4M$73.6M1.2%11.7%new
4Blue Owl Capital Holdings LPNEW3.6M$60.1M11.0%9.5%new
5Foresite Capital Management V, LLCNEW3.6M$59.5M20.6%9.4%new
6FMR LLCNEW2.9M$48.1M0.0%7.6%new
7Foresite Capital Management VI LLCNEW2.2M$36.8M6.5%5.8%new
8Cormorant Asset Management, LPNEW1.8M$30.3M2.0%4.8%new
9ORBIMED ADVISORS LLCNEW1.7M$28.0M0.5%4.4%new
10Aberdeen Group plcNEW935,718$15.6M0.0%2.5%new
11VANGUARD CAPITAL MANAGEMENT LLCNEW865,977$14.5M0.0%2.3%new
12FARALLON CAPITAL MANAGEMENT, L.L.C.NEW850,000$14.2M0.1%2.2%new
13PRICE T ROWE ASSOCIATES INC /MD/NEW811,784$13.6M0.0%2.1%new
14RTW INVESTMENTS, LPNEW700,000$11.7M0.1%1.8%new
15SanofiNEW672,778$11.2M1.8%1.8%new
16Rock Springs Capital Management LPNEW654,497$10.9M0.6%1.7%new
17Balyasny Asset Management L.P.NEW336,450$5.6M0.0%0.9%new
18Saturn V Capital Management LPNEW300,355$5.0M0.7%0.8%new
19UBS Group AGNEW293,297$4.9M0.0%0.8%new
20BlackRock, Inc.NEW292,086$4.9M0.0%0.8%new
21Affinity Asset Advisors, LLCNEW250,000$4.2M0.2%0.7%new
22GEODE CAPITAL MANAGEMENT, LLCNEW220,175$3.7M0.0%0.6%new
23SPHERA FUNDS MANAGEMENT LTD.NEW192,120$3.2M0.5%0.5%new
24MARSHALL WACE, LLPNEW184,260$3.1M0.0%0.5%new
25Eversept Partners, LPNEW172,999$2.9M0.2%0.5%new

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.